Transplantation Immunology
"Transplantation Immunology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection.
| Descriptor ID |
D014181
|
| MeSH Number(s) |
G12.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Immunology".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Immunology".
This graph shows the total number of publications written about "Transplantation Immunology" by people in this website by year, and whether "Transplantation Immunology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 3 | 2 | 5 |
| 2018 | 0 | 5 | 5 |
| 2019 | 0 | 3 | 3 |
| 2021 | 1 | 5 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Transplantation Immunology" by people in Profiles.
-
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. 2021 07 15; 131(14).
-
Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients. Front Immunol. 2021; 12:658896.
-
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Viruses. 2021 04 25; 13(5).
-
Editorial: COVID-19 immunology and organ transplantation. Curr Opin Organ Transplant. 2021 04 01; 26(2):258-265.
-
SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol. 2021 05 03; 32(5):1021-1024.
-
Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection. J Am Soc Nephrol. 2021 05 03; 32(5):1033-1036.
-
Anti-HLA and anti-SARS-CoV-2 antibodies in kidney transplant recipients with COVID-19. Transpl Int. 2021 03; 34(3):596-599.
-
Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). J Immunol Methods. 2021 05; 492:112994.
-
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front Immunol. 2020; 11:1091.
-
Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis. J Infect Dis. 2019 07 31; 220(5):752-760.